http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105330578-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70aef2798c1ee26b8209114883d74597 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 |
| filingDate | 2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6e710716704d94bda19016bb1b3b557 |
| publicationDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105330578-A |
| titleOfInvention | Compound for treating macular oedema and pharmaceutical composition thereof |
| abstract | The invention discloses a compound for treating macular oedema and a pharmaceutical composition thereof. The compound is as shown in the formula (I), wherein definitions of all symbols are as shown in the specification. The compound as shown in the formula (I) or its salt can be supplied in a non-invasive way to patients who need treatment of macular oedema. By the use of the compound, pain caused by drug application is mitigated. In addition, the pharmaceutical composition has little side effect and can be used as a conventional nonprescription drug. |
| priorityDate | 2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.